(Q41031284)

English

Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases

scientific article published on 25 August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases (English)

1 reference

Europe PubMed Central

25 September 2017

Gram-negative bacteria

0 references

carbapenem antibiotic

0 references

4

object named as

Neil Woodford

1 reference

Europe PubMed Central

25 September 2017

David M. Livermore

1

object named as

David M Livermore

1 reference

Europe PubMed Central

25 September 2017

2

object named as

Shazad Mushtaq

1 reference

Europe PubMed Central

25 September 2017

author name string

Marina Warner

3

1 reference

Europe PubMed Central

25 September 2017

language of work or name

0 references

publication date

25 August 2015

1 reference

Europe PubMed Central

25 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

25 September 2017

70

1 reference

Europe PubMed Central

25 September 2017

11

1 reference

Europe PubMed Central

25 September 2017

3032-3041

1 reference

Europe PubMed Central

25 September 2017

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Activity of mecillinam alone and in combination with other beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

The mechanism of action of mecillinam

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Heterogeneous hydrolytic features for OXA-48-like β-lactamases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Function of penicillin-binding protein 2 in viability and morphology of Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Kinetics of avibactam inhibition against Class A, C, and D β-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

In Escherichia coli, MreB and FtsZ direct the synthesis of lateral cell wall via independent pathways that require PBP 2.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Why spherical Escherichia coli dies: the inside story

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

In vitro activities of ceftazidime-avibactam and aztreonam-avibactam against 372 Gram-negative bacilli collected in 2011 and 2012 from 11 teaching hospitals in China

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV239

21 January 2018

Identifiers

10.1093/JAC/DKV239

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41031284&oldid=2093348224"